China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC – Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 5,500 shares, a decrease of 93.4% from the February 29th total of 82,800 shares. Currently, 1.0% of the shares of the company are short sold. Based on an average trading volume of 1,040,000 shares, the short-interest ratio is currently 0.0 days.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Renaissance Technologies LLC lifted its stake in China SXT Pharmaceuticals by 2,009.8% in the 1st quarter. Renaissance Technologies LLC now owns 451,500 shares of the company’s stock valued at $126,000 after purchasing an additional 430,100 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in shares of China SXT Pharmaceuticals during the 1st quarter worth approximately $31,000. Virtu Financial LLC bought a new position in China SXT Pharmaceuticals during the fourth quarter worth $48,000. Finally, Millennium Management LLC grew its holdings in China SXT Pharmaceuticals by 48.1% in the fourth quarter. Millennium Management LLC now owns 67,648 shares of the company’s stock worth $37,000 after purchasing an additional 21,963 shares during the period. Institutional investors own 5.02% of the company’s stock.
China SXT Pharmaceuticals Price Performance
China SXT Pharmaceuticals stock traded up $0.01 during midday trading on Thursday, hitting $1.69. The company’s stock had a trading volume of 24,820 shares, compared to its average volume of 591,606. China SXT Pharmaceuticals has a 1-year low of $1.56 and a 1-year high of $9.38. The company has a 50-day moving average price of $1.90 and a two-hundred day moving average price of $2.26.
About China SXT Pharmaceuticals
China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.
Featured Stories
- Five stocks we like better than China SXT Pharmaceuticals
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- Dividend Payout Ratio Calculator
- Disney Stock Catches 3 Upgrades In a Single Week
- Comparing and Trading High PE Ratio Stocks
- Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.